Both in Pharmaceuticals
Pasithea Therapeutics vs IGC Pharma
Over the past year KTTA returned −31.0% and IGC returned −49.9%; their daily moves had a correlation of 0.09.
KTTA −31.0% IGC −49.9%Growth of $1, one year, split-adjusted
| Metric | KTTA | IGC |
|---|---|---|
| Price | $0.5300 | $0.1950 |
| Market cap | $17.7M | $20.2M |
| Today | 0.00% | +4.84% |
| 1 month | +18.6% | −30.4% |
| 6 months | −37.6% | −38.7% |
| Year to date | −58.9% | −30.7% |
| 1 year | −35.0% | −51.5% |
| Revenue growth (YoY) | — | −19.2% |
| Gross margin | — | 18.1% |
| Net margin | — | −1107.9% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $45.7M | -$728.0K |
| Dividend yield | — | — |
| Volatility (60d) | 103.5% | 63.5% |
| Short % of float | 0.5% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).